Latest update on ABT-199 an interview of Dr John Seymour Australian lead investigator by Patient Power

[HAIRBEAR_UK]

"Dr. John Seymour, a CLL researcher, shares an update about an ongoing trial using the Bcl-2 inhibitor ABT-199, which received a dose modification following safety concerns. Dr. Seymour explains Phase I trial data that demonstrates the therapy's balance of safety and efficacy as well its promising potential for combination with other agents.

youtube.com/watch?v=ucXxydP...(Not working as expected?)

[jangreen]

I really enjoyed this down to earth video.Thanks

[AussieNeil Partner Administrator]

For more on ABT-199 see:

healthunlocked.com/cllsuppo...